SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-004087
Filing Date
2022-03-17
Accepted
2022-03-17 16:11:52
Documents
14
Period of Report
2022-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nktx-20220317.htm   iXBRL 8-K 60254
2 EX-99.1 nktx-ex99_1.htm EX-99.1 199855
3 GRAPHIC img220989892_0.jpg GRAPHIC 6297
  Complete submission text file 0000950170-22-004087.txt   403709

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktx-20220317.xsd EX-101.SCH 2478
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktx-20220317_pre.xml EX-101.PRE 11459
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktx-20220317_lab.xml EX-101.LAB 13996
8 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20220317_htm.xml XML 4889
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39370 | Film No.: 22748652
SIC: 2834 Pharmaceutical Preparations